Deniz Kirik

Deniz Kirik publication distribution in Neuroscience in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Neuroscience in 2026. The highlighted bar marks where Deniz Kirik sits on this spectrum.

Deniz Kirik D-index placement in Neuroscience in 2026

The chart shows the D-index (discipline H-index) distribution of Neuroscience scientists ranked by Research.com in 2026. The highlighted bar marks where Deniz Kirik sits on this spectrum.

Research.com Recognitions

• The Science Academy Society of Turkey - Bilim Akademisi Neuroscience
• The Science Academy Society of Turkey - Bilim Akademisi Neuroscience
• The Science Academy Society of Turkey - Bilim Akademisi Neuroscience

Overview

Best Publications

• Neuronal replacement from endogenous precursors in the adult brain after stroke

  Andreas Arvidsson;Tove Collin;Deniz Kirik;Zaal Kokaia

  3653
  Citations

• Parkinson-like neurodegeneration induced by targeted overexpression of alpha-synuclein in the nigrostriatal system.

  Deniz Kirik;Carl Rosenblad;Corinna Burger;Cecilia Lundberg

  868
  Citations

• Pharmacological validation of behavioural measures of akinesia and dyskinesia in a rat model of Parkinson's disease.

  M. Lundblad;M. Andersson;C. Winkler;C. Winkler;D. Kirik

  805
  Citations

• Characterization of behavioral and neurodegenerative changes following partial lesions of the nigrostriatal dopamine system induced by intrastriatal 6-hydroxydopamine in the rat

  Deniz Kirik;Carl Rosenblad;Anders Björklund

  786
  Citations

• Dopamine released from 5-HT terminals is the cause of L-DOPA-induced dyskinesia in parkinsonian rats.

  Manolo Carta;Thomas Carlsson;Deniz Kirik;Anders Björklund

  723
  Citations

• Long-term rAAV-mediated gene transfer of GDNF in the rat Parkinson's model: intrastriatal but not intranigral transduction promotes functional regeneration in the lesioned nigrostriatal system.

  Deniz Kirik;Carl Rosenblad;Anders Björklund;Ronald J. Mandel

  629
  Citations

• Towards a neuroprotective gene therapy for Parkinson's disease: use of adenovirus, AAV and lentivirus vectors for gene transfer of GDNF to the nigrostriatal system in the rat Parkinson model.

  Anders Björklund;Deniz Kirik;C Rosenblad;B Georgievska

  506
  Citations

• L-DOPA-induced dyskinesia in the intrastriatal 6-hydroxydopamine model of parkinson's disease: relation to motor and cellular parameters of nigrostriatal function.

  Christian Winkler;Christian Winkler;Deniz Kirik;Anders Björklund;M.Angela Cenci

  488
  Citations

• Nigrostriatal alpha-synucleinopathy induced by viral vector-mediated overexpression of human alpha-synuclein: a new primate model of Parkinson's disease.

  Deniz Kirik;Lucy E. Annett;Corinna Burger;Nicholas Muzyczka

  475
  Citations

• Neurturin exerts potent actions on survival and function of midbrain dopaminergic neurons

  Brian A. Horger;Merry C. Nishimura;Mark P. Armanini;Li-Chong Wang

  412
  Citations

• Protection and regeneration of nigral dopaminergic neurons by neurturin or GDNF in a partial lesion model of Parkinson's disease after administration into the striatum or the lateral ventricle

  Carl Rosenblad;Deniz Kirik;Brigitte Devaux;Barbara Moffat

  375
  Citations

• Continuous low-level glial cell line-derived neurotrophic factor delivery using recombinant adeno-associated viral vectors provides neuroprotection and induces behavioral recovery in a primate model of Parkinson's disease

  Andisheh Eslamboli;Biljana Georgievska;Rosalind M. Ridley;Harry F. Baker

  349
  Citations

• Hippocampal Lewy pathology and cholinergic dysfunction are associated with dementia in Parkinson's disease.

  Hélène Hall;Stefanie Reyes;Natalie Landeck;Chris Bye

  346
  Citations

• Localized striatal delivery of GDNF as a treatment for Parkinson disease

  Deniz Kirik;Biljana Georgievska;Anders Björklund

  338
  Citations

• Aberrant Sprouting and Downregulation of Tyrosine Hydroxylase in Lesioned Nigrostriatal Dopamine Neurons Induced by Long-Lasting Overexpression of Glial Cell Line Derived Neurotrophic Factor in the Striatum by Lentiviral Gene Transfer

  Biljana Georgievska;Deniz Kirik;Anders Björklund

  332
  Citations

• Studies on neuroprotective and regenerative effects of GDNF in a partial lesion model of Parkinson's disease.

  Anders Björklund;Carl Rosenblad;Christian Winkler;Deniz Kirik

  332
  Citations

• Identification of dopaminergic neurons of nigral and ventral tegmental area subtypes in grafts of fetal ventral mesencephalon based on cell morphology, protein expression, and efferent projections.

  Lachlan Thompson;Perrine Barraud;Elin Andersson;Deniz Kirik

  325
  Citations

• Cell transplantation in Parkinson's disease: how can we make it work?

  Christian Winkler;Deniz Kirik;Anders Björklund

  314
  Citations

• Microglia acquire distinct activation profiles depending on the degree of alpha-synuclein neuropathology in a rAAV based model of Parkinson's disease.

  Vanesa Sanchez-Guajardo;Fabia Febbraro;Deniz Kirik;Marina Romero-Ramos;Marina Romero-Ramos

  290
  Citations

• α-Synuclein expression and Nrf2 deficiency cooperate to aggravate protein aggregation, neuronal death and inflammation in early-stage Parkinson's disease

  Isabel Lastres-Becker;Ayse Ulusoy;Ayse Ulusoy;Nadia G. Innamorato;Gurdal Sahin

  287
  Citations

• Combined 5-HT1A and 5-HT1B receptor agonists for the treatment of L-DOPA-induced dyskinesia.

  Ana Muñoz;Qin Li;Fabrizio Gardoni;Elena Marcello

  284
  Citations